What is NDC 59762-0058?

59762-0058 is the product NDC for medroxyprogesterone acetate, Medroxyprogesterone acetate 5 mg/1 tablet, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for medroxyprogesterone acetate?

39 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

medroxyprogesterone acetate NDC 59762-0058

NDC codes

FDA NDC Directory

Product NDC (as listed)59762-0058Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59762-0058Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59762-0058-1	5976200580159762005801	100 TABLET in 1 BOTTLE (59762-0058-1)Marketed from Jan 2, 2019
59762-0058-2	5976200580259762005802	1000 TABLET in 1 BOTTLE (59762-0058-2)Marketed from May 11, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): medroxyprogesterone acetate
Generic name (nonproprietary): medroxyprogesterone acetate
Active ingredients: Medroxyprogesterone acetate — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Mylan Pharmaceuticals Inc.NDC labeler code 59762
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 011839
Marketing start: Aug 20, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Progesterone Congeners (Chemical structure)
Identifiers: Product ID 59762-0058_602a8237-8197-41ce-bfaf-03c6340cbe07SPL ID 602a8237-8197-41ce-bfaf-03c6340cbe07SPL set ID 2627eb11-06bf-4a45-9172-094468e3ca07RxCUI 1000114, 1000135, 1000141UNII C2QI4IOI2GUPC 0359762005618, 0359762005519
Pharmacologic class: Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459762005801 followed by a unit qualifier and the quantity

Package 59762-0058-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 21, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Medroxyprogesterone acetate tablets are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0.625 mg tablets.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59762-0058

What is NDC 59762-0058?: 59762-0058 is the product NDC for medroxyprogesterone acetate, Medroxyprogesterone acetate 5 mg/1 tablet, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: medroxyprogesterone acetate.
What is the active ingredient?: Medroxyprogesterone acetate.
Who is the labeler?: Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for medroxyprogesterone acetate?: 39 other product NDCs are listed under this name. See all medroxyprogesterone acetate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other medroxyprogesterone acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 2.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4666	70518-4666-0070518-4666-02
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals NY LLC	60219-1467	60219-1467-0160219-1467-02
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	REMEDYREPACK INC.	70518-4324	70518-4324-00
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 2.5 mg/1	TabletOral	Coupler LLC	67046-1480	67046-1480-03
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Xiromed LLC	70700-315	70700-0315-2570700-0315-27
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 10 mg/1	TabletOral	Northwind Health Company, LLC	51655-520	51655-0520-52
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals LLC	70121-1467	70121-1467-0270121-1467-05
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals LLC	70121-1480	70121-1480-01
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Eugia US LLC	55150-330	55150-0330-01
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Eugia US LLC	55150-329	55150-0329-0155150-0329-25

All 40 medroxyprogesterone acetate NDCs

Other NDCs under NDA 011839

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 011839
Product	Strength	Form · route	Labeler	Product NDC
medroxyprogesterone acetate	Medroxyprogesterone acetate 2.5 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-0055
medroxyprogesterone acetate	Medroxyprogesterone acetate 10 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-0056
Proveramedroxyprogesterone acetate	Medroxyprogesterone acetate 10 mg/1	TabletOral	Pharmacia & Upjohn Company LLC	0009-0051
Proveramedroxyprogesterone acetate	Medroxyprogesterone acetate 2.5 mg/1	TabletOral	Pharmacia & Upjohn Company LLC	0009-0065
Proveramedroxyprogesterone acetate	Medroxyprogesterone acetate 5 mg/1	TabletOral	Pharmacia & Upjohn Company LLC	0009-0287